Navigation Links
Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model
Date:4/21/2008

TRAVERSE CITY, Mich., April 21 /PRNewswire-FirstCall/ -- Versus Technology, Inc., (Versus) announces a collaboration with Cleveland Clinic's Glickman Urology & Kidney Institute that will combine Versus' Real-time Location Information System (RTLIS), VISion(TM), with the Cleveland Clinic's Glickman Urological & Kidney Institute's clinical workflow expertise to enhance Versus' clinic-based patient flow solution.

The collaboration will develop and document clinic best practices through increased efficiencies, automatic data capture, event automation, and system integrations. The goal of this initiative is to transform clinic processes improving patient safety and satisfaction while reducing unnecessary expenditures related to time spent searching and waiting.

These efforts include retooling basic processes and time-consuming, repetitive tasks with real-time location information passively collected through the Versus patented Infrared (IR) and Active RFID sensory network. By using technology to automate routine tasks, errors in data entry and delays due to the fast-paced clinic environment will be reduced or prevented. Caregivers will be free to dedicate more time to patient care.

"Versus has implemented hundreds of RTLIS solutions for automating processes within acute care, emergency, perioperative, long-term care and biomedical settings, so enhancing the Versus Location Information System to assist outpatient clinics is a natural progression in this growing marketplace. New technology allowing caregivers to provide for patients more effectively and efficiently is an important need of healthcare systems," said Paul Timmerman, Versus' VP of Business Development.

About Versus Technology, Inc.

Versus Technology, Inc. (OTC Pink Sheets: VSTI) (http://www.versustech.com) (Versus) is the leader in the development and sale of context-aware systems used for the management of patient
'/>"/>

SOURCE Versus Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Versus Technology Announces Fourth Quarter Results
2. Smart Home Cleaning: New Web Site Educates Consumers on Looking Clean Versus Being Clean
3. Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI
4. Versus Technology Announces First Quarter Results
5. Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006
6. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
7. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
8. ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table
9. eResearchTechnology, Inc. to Announce 2007 Third Quarter Results on November 1, 2007
10. Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits
11. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ALLAHASSEE, Fla. -- A Florida State University Col...g has discovered an important new layer of regulat...o a greater understanding of the way cancer begins...ciences at the College of Medicine, said the findi...ancer and could lead to the design of new drugs th...
(Date:11/21/2008)...SBURG, Pa., Nov. 21 Du...overnor Edward G. Rendell today remembered Lieuten...eacher, an important partner in public service, an...ia. , , "As the first woman elected lieuten...blic servant," said Governor Rendell. "Her family ...
(Date:11/21/2008)...N, Ariz., Nov. 21 The Pr...day announced that Craig A. Norris, the Company,s,...e Company,s Board of,Directors. Mr. Norris, appo...resignation of Steven I. Geringer and returns the ...on any committee of the Board. , Mr. Norris...
(Date:11/21/2008)...esearchers remain cautious about future antibiotic...IDAY, Nov. 21 (HealthDay News) -- People with mode...se (COPD) may be able to reduce the frequency of e...on antibiotic, a new report says. , The study,... American Journal of Respiratory and Critical Care...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:Long-Term Erythromycin Cut COPD Complications 2
...ecent study researchers say cholesterol may be act...cells healthy , however researchers also say that ...used inside the arteries, where it builds up as pl...okes. Researchers suggest an enzyme called ACAT2 m...
...an Medical Association, a recent study had shown t...sk of developing in next 20 years. Scientists have...agnosed with clinically localized prostate cancer ...observation or immediate or delayed androgen withd...
...lly created a new breed of mice that can reduce fr...or themselves.// The reactive oxygen of the free r... may lead to poor health and even death. The new r... towards increasing mortality through the free rad...
...be two separate conditions that frequently co-exis...umatism say that it is essential to treat depressi...imultaneously. The researchers had studied 33 wome...s the condition where patient feels extensive tend...
Other Medicine News:
(Date:11/20/2008)...SE III TRIAL SHOW SIGNIFICANT, DECREASES IN P..., IN, FIBROMYALGIA PAT...ium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz Pharm...xt Brussels: UCB),announced today positive prelim...e III pivotal clinical trials of sodium oxybate (J...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...ta from a prospective,registry presented this wee...eatment with the Trellis(R) Peripheral Infusion Sy...) successfully breaks up the blood clot in most,p...ue, called isolated pharmacomechanical thrombolysi...an current catheter-directed thrombolysis,(CDT) t...
(Date:11/19/2008)...Science Corporation,researcher, Dan Tinker, prese...ual Conference in Washington, DC this week indicat...ers. The computerized brain plasticity-based,Bra...at target auditory and,language systems. The exe...ents in cognition by improving speed and accuracy ...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Using Early Stage Commercialization Activities to Build Long Term Success for the Bottom Line 8451 1Using Early Stage Commercialization Activities to Build Long Term Success for the Bottom Line 8451 2This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 1This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 2This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 3GeneGo Integrates With Cytoscape 2266 1GeneGo Integrates With Cytoscape 2266 2Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2264 1Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2264 2
...07 - Roche today announced,results of a small stud... treatment with Peg-Intron(R) (peginterferon alfa-... first 12 weeks, were,able to complete 12 weeks of... and ribavirin. Furthermore, 92 percent of,these p...rse of,treatment with PEGASYS. The data, which wer...
...rstCall/ -- Bristol-Myers,Squibb Company (NYSE: BM...ich showed that treatment with Baraclude (entecavi...adefovir at 48 weeks,-- a result that was also see...a from an open-label, randomized viral kinetics st...tigen (HBeAg),positive patients were presented at ...
Other Medicine Technology:Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...um Eppendorf Style Low Binding, Graduated Pipet Ti...Pipettors.Reduces DNA and protein binding. Non-rea... completely by automation. RNAse & DNAse free. AVR...nd 10 racks/cs. AVR100 is the Cell Rack packaged 9...
Packed conveniently in plastic-wrapped racks of 96 tips, Sterilized Diamond- Tips are ready to useno need to autoclave. Sterilized Diamond Tips are irradiated by gamma-rays for more efficient sterili
Like all Gilson disposable pipette tips, TowerPacks are available in a sterilized version. Each Sterilized TowerPack is individually wrapped in medical device-quality plastic to help protect tips fro
Medicine Products: